The global Microarray Biochips market was valued at US$ 1001.4 million in 2019 and it is expected to reach US$ 1830.7 million by the end of 2026, growing at a CAGR of 8.9% during 2021-2026.
Microarray or biochip is a lab-oriented microscope slide that is usually made of glass, silicon chip, or nylon membrane. It is a 2D array (sometimes 3D) whose surface is provided with thousands of minute pores in defined positions. The microarray is a recently developed technology and was discovered only two decades ago. It is mostly used in cancer research and in the pharmacological treatment of other diseases like oral lesions. It enables researchers to investigate and analyze the expression of thousands of genes in a single reaction and address various issues.
Illumina and Thermo Fisher Scientific are the two largest companies in the industry, accounting for more than 74 percent of 2018 revenue combined. In terms of production value, the United States occupies the absolute position, with production value accounting for more than 86%.
Global Microarray Biochips Market: Drivers and Restrains
The research report has incorporated the analysis of different factors that augment the market’s growth. It constitutes trends, restraints, and drivers that transform the market in either a positive or negative manner. This section also provides the scope of different segments and applications that can potentially influence the market in the future. The detailed information is based on current trends and historic milestones. This section also provides an analysis of the volume of production about the global market and about each type from 2016 to 2027. This section mentions the volume of production by region from 2016 to 2027. Pricing analysis is included in the report according to each type from the year 2016 to 2027, manufacturer from 2016 to 2021, region from 2016 to 2021, and global price from 2016 to 2027.
A thorough evaluation of the restrains included in the report portrays the contrast to drivers and gives room for strategic planning. Factors that overshadow the market growth are pivotal as they can be understood to devise different bends for getting hold of the lucrative opportunities that are present in the ever-growing market. Additionally, insights into market expert’s opinions have been taken to understand the market better.
Global Microarray Biochips Market: Segment Analysis
The research report includes specific segments by region (country), by manufacturers, by Type and by Application. Each type provides information about the production during the forecast period of 2016 to 2027.
Key Companies profiled in this report are Illumina, Thermo Fisher Scientific, Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, BioChain, Sengenics, Applied Microarrays, US Biomax and more in terms of market share by sales, revenue, average pricing, product type, margins, recent developments etc.
Segment by Type
- DNA Microarray
- Protein Microarray
Segment by Application
- Drug Discovery
Table of Content:
1 Microarray Biochips Market Overview
2 Market Competition by Manufacturers
3 Production and Capacity by Region
4 Global Microarray Biochips Consumption by Region
5 Production, Revenue, Price Trend by Type
6 Consumption Analysis by Application
7 Key Companies Profiled
8 Microarray Biochips Manufacturing Cost Analysis
9 Marketing Channel, Distributors and Customers
10 Market Dynamics
11 Production and Supply Forecast
12 Consumption and Demand Forecast
13 Forecast by Type and by Application (2022-2027)
14 Research Finding and Conclusion
15 Methodology and Data Source
Company Name: The Market Reports
Contact Person: Shirish Gupta